AI-generated summary
The authors studied whether near-infrared II laser light (1064 and 1270 nm) could support T cells in mouse models of breast cancer. They report that brief laser treatments reduced PD-1 expression on CD8+ T cells and that laser-treated T cells delayed tumor growth after adoptive transfer. They also report that specific laser parameters augmented an immune checkpoint inhibitor's effect on tumor growth.
- Who or what was studied
- Syngeneic mouse model of breast cancer and ex vivo CD8+ T cells
- Wavelengths
- 1064, 1270 nm
- Limits stated in the abstract
- The study was conducted in mice and ex vivo cells, so the findings may not translate directly to human patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on faseb.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1270 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared, Laser, Photobiomodulation, Penetration depth, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.